Company Filing History:
Years Active: 2014
Title: The Innovations of Matthew R Young
Introduction
Matthew R Young is an accomplished inventor based in Ijamsville, Maryland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that target the nuclear factor kappa B (NF-κB) pathway. His work has the potential to impact various medical conditions associated with this pathway.
Latest Patents
Matthew R Young holds a patent for a "Nuclear factor kappa B pathway inhibitor composition and use of same." This invention includes a pharmaceutical composition comprising a compound of a specific formula, along with its pharmaceutically acceptable salts, prodrugs, hydrates, or solvates. The patent also outlines methods for treating or preventing conditions linked to increased expression and/or activity of the NF-κB pathway, as well as methods for diagnosing such conditions in individuals.
Career Highlights
Matthew is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His role at this prestigious institution allows him to engage in groundbreaking research and development in the pharmaceutical field.
Collaborations
Some of his notable coworkers include Curtis J Henrich and Moon-II Kang, who contribute to the collaborative environment that fosters innovation and research excellence.
Conclusion
Matthew R Young's work exemplifies the intersection of innovation and healthcare, showcasing how targeted pharmaceutical compositions can lead to advancements in treatment and diagnosis. His contributions are vital to the ongoing efforts in medical research and development.